In addition to ASO therapies, siRNA drugs targeting APOC3 are rapidly advancing in clinical development
Many users report optimal results at this level without needing to progress further
[1] Adhikari, R., Jha, K., Dardari, Z., Heyward, J., Blumenthal, R.S., Eckel, R.H., Alexander, G.C., Blaha, M.J., (2022)
Dermal filling involves an injection of Hyaluronic Acid (a natural substance produced by the body) under the skin in and around targeted areas of your face
However, it provides only a limited solution for a certain number of drugs and patients, 4 while failing to address the root causes of patent abuse
At first, 413 papers were identified from the databases, out of which 44 duplicates were removed, leaving 369 papers to be screened using the title and abstract